Michael Crowley - Aug 9, 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, GBL Commercial Operations
Signature
/s/ Michael Crowley
Stock symbol
BIO
Transactions as of
Aug 9, 2021
Transactions value $
-$1,846,116
Form type
4
Date filed
8/10/2021, 11:58 AM
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $419K +3K +81.77% $139.56 6.67K Aug 9, 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale -$1.94M -2.57K -38.54% $754.80 4.1K Aug 9, 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Sale -$325K -430 -10.49% $755.72 3.67K Aug 9, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -3K -100% $0.00* 0 Aug 9, 2021 Bio-Rad A Common Stock 3K $139.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $754.52 to $755.39, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $755.52 to $756.30, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 11, 2016, which was the first anniversary of the date on which the option was granted.